2024-05-02 | Sale | ACADIA Pharmaceuticals Inc. ACAD | CEO | 11,427 0.0069% | $16.94 | $193,573 | -11.01% | |
2024-04-08 | Sale | ACADIA Pharmaceuticals Inc. ACAD | CEO | 26,574 0.0162% | $17.87 | $474,877 | -13.43% | |
2024-03-27 | Sale | ACADIA Pharmaceuticals Inc. ACAD | CEO | 17,714 0.0106% | $17.90 | $317,081 | -13.08% | |
2024-02-26 | Sale | ACADIA Pharmaceuticals Inc. ACAD | CEO | 5,577 0.0032% | $24.67 | $137,585 | -34.25% | |
2024-01-08 | Sale | ACADIA Pharmaceuticals Inc. ACAD | CEO | 3,732 0.0023% | $29.96 | $111,811 | -40.14% | |
2023-10-06 | Sale | ACADIA Pharmaceuticals Inc. ACAD | CEO | 51,563 0.0319% | $21.96 | $1.13M | +2.77% | |
2023-07-14 | Sale | ACADIA Pharmaceuticals Inc. ACAD | CEO | 100,000 0.0575% | $30.04 | $3M | -27.91% | |
2023-07-12 | Sale | ACADIA Pharmaceuticals Inc. ACAD | CEO | 55,104 0.0329% | $25.05 | $1.38M | -10.25% | |
2023-07-11 | Sale | ACADIA Pharmaceuticals Inc. ACAD | CEO | 16,498 0.0102% | $25.00 | $412,450 | -6.6% | |
2023-05-01 | Sale | ACADIA Pharmaceuticals Inc. ACAD | CEO | 7,806 0.0047% | $21.18 | $165,331 | +10.67% | |
2023-04-06 | Sale | ACADIA Pharmaceuticals Inc. ACAD | CEO | 8,582 0.0052% | $18.16 | $155,849 | +31.17% | |
2023-02-24 | Sale | ACADIA Pharmaceuticals Inc. ACAD | CEO | 3,851 0.0024% | $18.78 | $72,322 | +26.85% | |
2023-01-09 | Sale | ACADIA Pharmaceuticals Inc. ACAD | CEO | 3,904 0.0024% | $17.13 | $66,877 | +34.98% | |
2022-10-15 | Sale | ACADIA Pharmaceuticals Inc. ACAD | CEO | 2,804 0.0017% | $15.81 | $44,331 | ||
2022-04-29 | Sale | ACADIA Pharmaceuticals Inc. ACAD | CEO | 5,483 0.0033% | $18.18 | $99,691 | -8.95% | |
2022-02-23 | Sale | ACADIA Pharmaceuticals Inc. ACAD | CEO | 3,928 0.0023% | $23.80 | $93,486 | -32% | |
2022-01-06 | Sale | ACADIA Pharmaceuticals Inc. ACAD | CEO | 3,718 0.0023% | $23.05 | $85,700 | -28.22% | |
2021-10-18 | Sale | ACADIA Pharmaceuticals Inc. ACAD | CEO | 2,963 0.0018% | $17.41 | $51,586 | +7.22% | |
2021-04-30 | Sale | ACADIA Pharmaceuticals Inc. ACAD | CEO | 7,850 0.0048% | $20.33 | $159,591 | +6.52% | |
2021-02-04 | Sale | ACADIA Pharmaceuticals Inc. ACAD | CEO | 14,195 0.0088% | $50.61 | $718,409 | -57.96% |